Zevra Therapeutics (ZVRA) Insider Trading & Ownership $9.43 -0.06 (-0.63%) (As of 11/26/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Zevra Therapeutics (NASDAQ:ZVRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.40%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$144,300.00Number OfInsiders Selling(Last 12 Months)0 Get ZVRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Zevra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ZVRA Insider Buying and Selling by Quarter Ad Colonial MetalsA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Zevra Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/11/2024Corey Michael WattonDirectorBuy500$7.92$3,960.00 7/17/2024R. Laduane CliftonCFOBuy2,000$6.77$13,540.00 7/16/2024Thomas AndersonDirectorBuy10,000$6.81$68,100.00 7/12/2024John B BodeDirectorBuy10,000$5.87$58,700.00 (Data available from 1/1/2013 forward) ZVRA Insider Trading Activity - Frequently Asked Questions Who is on Zevra Therapeutics's Insider Roster? The list of insiders at Zevra Therapeutics includes Corey Michael Watton, John B Bode, Joshua Schafer, Matthew R Plooster, R. Laduane Clifton, Richard W Pascoe, Tamara A Seymour, Thomas Anderson, and Timothy J Sangiovanni. Learn more on insiders at ZVRA. What percentage of Zevra Therapeutics stock is owned by insiders? 2.40% of Zevra Therapeutics stock is owned by insiders. Learn more on ZVRA's insider holdings. Which Zevra Therapeutics insiders have been buying company stock? The following insiders have purchased ZVRA shares in the last 24 months: Corey Michael Watton ($9,434.25), John B Bode ($160,400.00), Joshua Schafer ($17,205.00), Matthew R Plooster ($46,200.00), R. Laduane Clifton ($39,221.75), Richard W Pascoe ($42,000.00), Tamara A Seymour ($2,501.58), Thomas Anderson ($68,100.00), and Timothy J Sangiovanni ($4,968.00). How much insider buying is happening at Zevra Therapeutics? Insiders have purchased a total of 75,184 ZVRA shares in the last 24 months for a total of $390,030.58 bought. Zevra Therapeutics Key ExecutivesMr. Neil F. McFarlane (Age 51)President, CEO & Director Compensation: $503.77kMs. Christal M. M. Mickle M.A. (Age 45)Co-Founder & Chief Development Officer Compensation: $622.36kMr. R. LaDuane Clifton CPA (Age 52)CFO, Secretary & Treasurer Compensation: $658.43k1 recent tradesMr. Joshua M. Schafer M.B.A. (Age 52)Chief Commercial Officer & Executive VP of Business Development Compensation: $766.07kDr. Sven Guenther Ph.D. (Age 52)Chief Scientific Officer Compensation: $497.26kMs. Nichol L. OchsnerVice President of Investor Relations & Corporate CommunicationsMr. Rahsaan W. Thompson J.D. (Age 53)Chief Legal Officer, Secretary & Compliance Officer Ms. Alison PetersChief People OfficerDr. Christopher M. Lauderback Ph.D. (Age 49)Senior Vice President of Manufacturing Dr. Rene A. Braeckman Ph.D.Senior Vice President of Clinical Development More Insider Trading Tools from MarketBeat Related Companies NewAmsterdam Pharma Insider Trades Harmony Biosciences Insider Trades Apogee Therapeutics Insider Trades Disc Medicine Insider Trades Tarsus Pharmaceuticals Insider Trades Xencor Insider Trades Arvinas Insider Trades Recursion Pharmaceuticals Insider Trades Immunocore Insider Trades Kiniksa Pharmaceuticals Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ZVRA) was last updated on 11/26/2024 by MarketBeat.com Staff From Our Partners❗[Investor Alert] Under-the-Radar TechWhile most investors are caught up in cryptocurrencies, AI stocks, or Jim Cramer's latest "hot pick…" One c...TuneGO | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zevra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zevra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
